SZ 363 Pill - yellow capsule/oblong
Pill with imprint SZ 363 is Yellow, Capsule/Oblong and has been identified as Repaglinide 2 mg. It is supplied by Sandoz Inc.
Repaglinide is used in the treatment of Type 2 Diabetes and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Repaglinide 2 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for SZ 363
Repaglinide
- Imprint
- SZ 363
- Strength
- 2 mg
- Color
- Yellow
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Meglitinides
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sandoz Inc.
- National Drug Code (NDC)
- 00781-5150 (Discontinued)
- Inactive Ingredients
-
corn starch,
calcium phosphate dibasic anhydrous,
glycerin,
magnesium stearate,
meglumine,
microcrystalline cellulose,
poloxamer 188,
polacrilin potassium,
magnesium silicate,
ferric oxide yellow
Note: Inactive ingredients may vary.
More about repaglinide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (12)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: meglitinides
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.